Korro Bio Rings the Nasdaq Stock Market Closing Bell
Korro Bio (Nasdaq: KRRO), a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Ram Aiyar, President and CEO, rings the Closing Bell.